AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

RISEDRONATE

15 registrations across 3 African markets— 6 active

Markets with RISEDRONATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
RISONEL
Comprimé pelliculé / 35 mg
🇹🇳TunisiaADWYAexpiredDec 2022
RISONEL
Comprimé pelliculé / 35 mg
🇹🇳TunisiaADWYAexpiredOct 2014
RISONEL
Comprimé pelliculé / 35 mg
🇹🇳TunisiaADWYAexpiredOct 2014
OSTENEL
Comprimé pelliculé / 35 mg
🇹🇳TunisiaDAR-ESSAYDALI.expiredAug 2014
AKTONATE
Comprimé pelliculé / 35 mg
🇹🇳TunisiaPHARMAGHREBexpiredApr 2010
AKTONATE
Comprimé pelliculé / 35 mg
🇹🇳TunisiaPHARMAGHREBexpiredApr 2010
OSTENEL
Comprimé pelliculé / 35 mg
🇹🇳TunisiaDAR-ESSAYDALI.expiredNov 2009
AKTONATE
Comprimé pelliculé / 35 mg
🇹🇳TunisiaPHARMAGHREBexpiredJul 2009
OSTENEL
Comprimé pelliculé / 35 mg
🇹🇳TunisiaDAR-ESSAYDALI.expiredDec 2006
ETANORDES 35 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
ODRON 35 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
NOPOROSE 35 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
ACTONEL
COMPRIME PELLICULE
🇲🇦Moroccoactive
ACTONEL
COMPRIME PELLICULE
🇲🇦Moroccoactive
NOPOROSE 35 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive

RISEDRONATE in Africa — Regulatory Overview

RISEDRONATE is registered across 3 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 6 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.